[O-22] Oral Session 22
Dementia (biomarker)

[O-22-7] Reconsideration of clinical diagnosis of Alzheimer's disease based on biomarkers and APOE genotype

^○Kensaku Kasuga¹, Tamao Tsukie¹, Masataka Kikuchi², Norikazu Hara¹, Akinori Miyashita¹, Ryozo Kuwano³, Takeshi Iwatsubo⁴, Takeshi Ikeuchi¹, Japanese Alzheimer's Disease Neuroimaging Intiative¹ (1.Department of Molecular Genetics, Brain Research Institute, Niigata University, 2.Department of Genome Informatics, Graduate School of Medicine, Osaka University, 3.Asahigawaso Medical-Welfare Center, Asahigawaso Research Institute, 4.Department of Neuropathology, Graduate School of Medicine, The University of Tokyo)